Biotechnology and Sciences Chemical and Materials Engineering and Designs High Tech and Electrical Trade Mark and Domain Names
Find an expert by name If you know the name of the attorney you need, start here.
Patents Drafting Filing and prosecution Infringement and validity Opposition and appeal Strategy View all
Trade marks Dispute management Domain names Enforcement Filing and prosecution Licences and assignments Search analysis Strategy View all
Design Infringement and validity Registration View all
Support Online services Records and renewals Searching and watching BoultRenew View all
People
Find an expert by name If you know the name of the attorney you need, start here.
Find an expert by group Choose a group to learn more about the team and how to contact us.
Sign up to our updates
Signing up means you can keep on top of the latest IP updates and publications from our attorneys.
Click here to sign upTrainee Is this firm right for me? Community, diversity and inclusion Graduate training programme Join us Talk to us
Current vacancies
We have some great opportunities right now at Boult Wade Tennant.
View all vacanciesNon-Prejudicial Disclosures
In general, any public disclosure by any person before the filing date (or the priority date if priority is claimed) of a UK or European patent application can be cited as “prior art” when assessing novelty and inventive step. Prior art typically includes published patent documents, scientific papers and information available on the internet, but can also include evidence of prior use. It is therefore essential that a patent application for a product is filed before the product is publicly disclosed. If an applicant discloses their product, such as in marketing material, before filing a patent application, then their own disclosure can be cited as prior art and may render their patent application lacking in novelty or inventive step.
There are, however, two exceptions in which a public disclosure prior to the filing date of a UK or European patent application is disregarded when assessing novelty and inventive step. The first exception is any public disclosure that results from an evident abuse in relation to the applicant or inventor, such as by the disclosure being in breach of confidentiality or based upon unlawfully obtained information. The second exception is any display of a product at certain international exhibitions, provided that the applicant identifies this disclosure with their application and files a supporting certificate meeting certain requirements.
These two exceptions will only be applied if the UK or European application has a filing date within six months of the abusive disclosure or display at the international exhibition. The priority date is not taken into account. In order to benefit from these two exceptions a UK or European patent application should therefore be filed within six months of the disclosure, regardless of any priority claim.
Author